APA (7th ed.) Citation

JH, R., SM, A., REJ, M., Ö, M., M, B., IM, C., . . . MH, A. (2026). Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: Evidence from immunologic and clinical correlates. Signal transduction and targeted therapy, 11(1), . https://doi.org/10.1038/s41392-026-02626-3

Chicago Style (17th ed.) Citation

JH, Ruders, Ahmad SM, Mortensen REJ, Met Ö, Byrdal M, Chen IM, Theile S, Holmström MO, and Andersen MH. "Rationale for Multi-epitope TGFβ Vaccination in Pancreatic Cancer: Evidence from Immunologic and Clinical Correlates." Signal Transduction and Targeted Therapy 11, no. 1 (2026). https://doi.org/10.1038/s41392-026-02626-3.

MLA (9th ed.) Citation

JH, Ruders, et al. "Rationale for Multi-epitope TGFβ Vaccination in Pancreatic Cancer: Evidence from Immunologic and Clinical Correlates." Signal Transduction and Targeted Therapy, vol. 11, no. 1, 2026, https://doi.org/10.1038/s41392-026-02626-3.